Publication number: 20160030585
Abstract: The invention provides a conjugate comprising a biomolecule linked to a fatty acid via a linker wherein the fatty acid has the following Formulae A1, A2 or A3: wherein R1, R2, R3, R4, Ak, n, m and p are defined herein. The invention also relates to a method for manufacturing the conjugate of the invention such as GDF15 conjugate, and its therapeutic uses such as treatment or prevention of metabolic disorders or diseases, type 2 diabetes mellitus, obesity, pancreatitis, dyslipidemia, alcoholic and nonalcoholic fatty liver disease/steatohepatitis and other progressive liver diseases, insulin resistance, hyperinsulinemia, glucose intolerance, hyperglycemia, metabolic syndrome, hypertension, cardiovascular disease, atherosclerosis, peripheral arterial disease, stroke, heart failure, coronary heart disease, diabetic complications (including but not limited to chronic kidney disease), neuropathy, gastroparesis and other metabolic disorders.
Type:
Application
Filed:
June 12, 2015
Publication date:
February 4, 2016
Applicant:
NOVARTIS AG
Inventors:
David Weninger BARNES, Ken YAMADA, Chikwendu IBEBUNJO, Alokesh DUTTAROY, Louis Clare KIRMAN, Alexandra Marshall BRUCE, Aimee Richardson USERA, Frederic ZECRI, Jun YUAN, Changgang LOU, Aaron KANTER, Avirup BOSE